Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe C Wu

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Protein Science : a Publication of the Protein Society|January 23, 2010
Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometryHui-Min Zhang, Xiu Yu, Michael J Greig, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.
Circulation Research|May 15, 2012
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5Jenny X Chen, Markus Krane, Marcus-Andre Deutsch, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitorsHu Liu, Cyrille Kuhn, Frederic Feru, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modificationsBrett R Ullman, Teresa Aja, Thomas L Deckwerth, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsKetan S Gajiwala, Joe C Wu, James Christensen, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Protein Science : a Publication of the Protein Society|January 23, 2010
Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometryHui-Min Zhang, Xiu Yu, Michael J Greig, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.
Circulation Research|May 15, 2012
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5Jenny X Chen, Markus Krane, Marcus-Andre Deutsch, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitorsHu Liu, Cyrille Kuhn, Frederic Feru, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modificationsBrett R Ullman, Teresa Aja, Thomas L Deckwerth, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsKetan S Gajiwala, Joe C Wu, James Christensen, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.
Pageof 3